CLOFAZIMINE (kloe FA zi meen) is an anti-infective medicine. It is used to treat leprosy.
Clofazimine is a fat-soluble iminophenazine dye used in combination with
rifampicin and dapsone as multidrug therapy (MDT) for the treatment of leprosy.
Consumer information about the medication CLOFAZIMINE - ORAL (Lamprene),
includes side effects, drug interactions, recommended dosages, and storage ...
Nov 5, 2008 ... Lamprene, clofazimine, is an antileprosy agent available as soft gelatin capsules
for oral administration. Each capsule contains 50 mg of ...
Oct 20, 2011 ... Clofazimine, a lipophilic riminophenazine antibiotic, possesses both
antimycobacterial and anti-inflammatory activities. However, its efficacy ...
Medscape - Leprosy dosing for Lamprene (clofazimine), frequency-based
adverse effects, comprehensive interactions, contraindications, pregnancy &
Jun 13, 2005 ... Clofazimine also has a marked anti-inflammatory effect and is given to control the
leprosy reaction, erythema nodosum leprosum. (From AMA ...
clofazimine | C27H22Cl2N4 | CID 2794 - structure, chemical names, physical and
chemical properties, classification, patents, literature, biological activities, ...
Most of the existing production of clofazimine by Novartis is donated through
WHO for the supply of multidrug therapy (MDT) packs for the treatment of leprosy
Sep 1, 2015 ... Clofazimine is taken to treat leprosy (Hansen's disease). It is sometimes given
with other medicines for leprosy. When this medicine is used to ...